Copyright
©The Author(s) 2024.
World J Gastroenterol. Jan 14, 2024; 30(2): 184-195
Published online Jan 14, 2024. doi: 10.3748/wjg.v30.i2.184
Published online Jan 14, 2024. doi: 10.3748/wjg.v30.i2.184
Figure 2 Flow diagram of antibiotic-susceptibility-guided therapy.
qPCR: Quantitative polymerase chain reaction; UBT: Urea Breath Test; ITT: Intention-to-treat; PP: Per-protocol; A: Amoxicillin; B: Bismuth; C: Clarithromycin; F: Furazolidone; L: Levofloxacin; MH: Minocycline hydrochloride; P: Proton pump inhibitor; CLAR: Clarithromycin-resistant; CLAS: Clarithromycin-susceptible; LFXR: Levofloxacin-resistant; LFXS: Levofloxacin-susceptible.
- Citation: Wang YM, Chen MY, Chen J, Zhang XH, Feng Y, Han YX, Li YL. Success of susceptibility-guided eradication of Helicobacter pylori in a region with high secondary clarithromycin and levofloxacin resistance rates. World J Gastroenterol 2024; 30(2): 184-195
- URL: https://www.wjgnet.com/1007-9327/full/v30/i2/184.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i2.184